Testing effectiveness (Phase 2)Not Yet RecruitingNCT07173933
What this trial is testing
Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD)
Who this might be right for
Wilson Disease
GeneCradle Inc 15